文献速递血液透析通路

头静脉与贵要静脉肱动脉动静脉瘘的长期通畅性:单中心回顾性研究

Long-Term Patency Between Brachiocephalic and Brachiobasilic Fistulas: A Single Institution Review.
PubMed 文献 · Ann Vasc Surg · 2024-07-01

该单中心回顾性研究纳入2019至2022年184例患者(头静脉肱动脉瘘BCF 109例,贵要静脉肱动脉瘘BBF 75例),比较两种上肢透析通路的通畅性。BBF组1年主要辅助通畅率显著低于BCF组(67% vs 80%,P=0.030),但1年主要通畅率与2年次要通畅率无显著差异;BBF组死亡率显著更高(19% vs 6%,P=0.005),且手术时间更长、出血更多。

要点

  • BBF组1年主要辅助通畅率显著低于BCF组(67% vs 80%,P=0.030)
  • BBF组与BCF组1年主要通畅率无显著差异(41% vs 47%,P=0.547)
  • BBF组死亡率显著高于BCF组(19% vs 6%,P=0.005)

核心结论

  • 在单中心回顾性比较中,BBF与BCF在主要通畅率或次要通畅率方面未见差异。
  • 即使BBF静脉尺寸更大,也未在长期通畅性或通路废弃方面带来获益。
  • BBF未减少维持通畅所需的干预操作,且手术时间更长、出血更多,死亡率更高。
  • 作者认为,对于必须使用上肢部位的患者,当头静脉条件满意时,首选使用头静脉,因其不会对长期通畅性产生负面影响。

研究设计与样本

  • 单中心回顾性研究,纳入2019年至2022年间接受BCF或BBF的患者,按手术方式分为BCF组和BBF组。
  • 共纳入184例患者,其中BCF组109例(59%),BBF组75例(41%)。
  • 收集数据包括人口统计学特征、静脉尺寸、隧道式导管和既往通路史。
  • 主要结局包括主要通畅率(PP)、主要辅助通畅率(PAP)和次要通畅率(SP);次要结局包括30天并发症、通路废弃、干预次数和死亡率。
  • 采用线性回归、Kaplan-Meier法和log-rank检验进行统计分析。

主要发现

  • 除体重指数和静脉尺寸外,两组人口统计学特征无差异;BBF组静脉尺寸4 mm vs BCF组3.6 mm(P=0.020)。
  • BBF组与BCF组1年主要通畅率无差异(41% vs 47%,P=0.547)。
  • BBF组与BCF组2年次要通畅率无差异(73% vs 84%,P=0.058)。
  • BCF组1年主要辅助通畅率显著高于BBF组(80% vs 67%,P=0.030)。
  • BBF组与BCF组伤口并发症(1% vs 0%,P=0.408)、通路废弃(35% vs 28%,P=0.260)和干预次数(1 vs 1,P=0.712)均无差异。

临床怎么用

  • 作者认为,对于必须使用上肢部位的患者,当头静脉条件满意时,首选使用头静脉,因其不会对长期通畅性产生负面影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dialysis access is a fundamental procedure performed by vascular surgeons. Commonly, upper extremity access is utilized via a brachiobasilic fistula (BBF) or brachiocephalic fistula (BCF). BCF is preferred due to ease compared to BBF without documented improved function. Few studies compare patency outcomes between BBF and BCF over time. Our goal was to evaluate the difference in outcomes between BBF and BCF. METHODS: This is a retrospective review of patients with BCF or BBF between 2019 and 2022. Patients were split by procedure: BCF and BBF. Data collected included demographics, vein size, tunneled catheter, and previous access. Primary outcomes included primary patency (PP), primary assisted patency (PAP) and secondary patency (SP). Secondary outcomes included 30-day complications, access abandonment, interventions and mortality. Linear regression, Kaplan-Meier, and log-rank test were performed. RESULTS: Our study had 184 patients, 109 (59%) with BCF and 75 (41%) with BBF. There were no differences in demographics except for body mass index and vein size (BBF: 4 vs. BCF: 3.6 mm, P = 0.020). There was no difference in PP at 1 year (41% vs. 47%, P = 0.547) or SP at 2 years (73% vs. 84%, P = 0.058) in BBF versus BCF. However, PAP was significantly greater in BCF (80% vs. 67%, P = 0.030) at 1 year. Secondary outcomes revealed no difference in wound complications (1% vs. 0%, P = 0.408), access abandonment (35% vs. 28%, P = 0.260), or number of interventions (1 vs. 1, P = 0.712) in BBF versus BCF. Mortality was significantly greater in the BBF patients (19% vs. 6%, P = 0.005). On adjusted analysis, BBF had 43 min longer operative time (P < 0.001) and 22 cc greater blood loss (P < 0.0001). CONCLUSIONS: In this single center review comparing BBF and BCF, no difference was seen between BBF and BCF in terms of PP or SP. Even with larger vein size, BBF did not confer a benefit in long term patency or access abandonment. Additionally, BBF did not confer decreased procedures to maintain patency and BBF had greater operative length and blood loss, as well as mortality. We believe this study demonstrates that for patients who must use an upper extremity location, when the cephalic vein is satisfactory, using the cephalic vein is preferred as it does not negatively impact long-term patency.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Patel RJ, Hamouda M, Straus S, et al. Long-Term Patency Between Brachiocephalic and Brachiobasilic Fistulas: A Single Institution Review. Ann Vasc Surg. 2024. PMID: 38960096. doi:10.1016/j.avsg.2024.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。